175 related articles for article (PubMed ID: 35844442)
1. Clinical Efficacy of Immunoglobulin Combined with Glucocorticoids in the Treatment of Oculomotor Myasthenia Gravis in Children and the Effect on Serum Immunity.
Fan L; Yang Y; Zhang F; Huang F
Comput Math Methods Med; 2022; 2022():1772881. PubMed ID: 35844442
[TBL] [Abstract][Full Text] [Related]
2. Effect of glucocorticoid combined with gamma globulin in treatment of children with myasthenia gravis and its effects on immune globulin and complement of children.
Wang MG; Huang XX; Yao D; An Q; Deng XQ
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2404-8. PubMed ID: 27338067
[TBL] [Abstract][Full Text] [Related]
3. [Clinical effect of different immunosuppressive treatment regimens in children with ocular myasthenia gravis: a retrospective analysis].
Wang RY; Chen H; Huang ZX; Chen Y; Zhong JM
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Oct; 25(10):1034-1039. PubMed ID: 37905760
[TBL] [Abstract][Full Text] [Related]
4. Effects of Plasma Exchange Combined with Immunoglobulin Therapy on Consciousness, Immune Function, and Prognosis in Patients with Myasthenia Gravis Crisis: A Prospective Randomized Test.
Peng X; Xie XB; Tan H; Zhang D; Jiang BT; Liu J; Li S; Chen YR; Xie TY
Comput Math Methods Med; 2022; 2022():7796833. PubMed ID: 35813442
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids for myasthenia gravis.
Schneider-Gold C; Gajdos P; Toyka KV; Hohlfeld RR
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002828. PubMed ID: 15846640
[TBL] [Abstract][Full Text] [Related]
6. [Clinical value of the immune parameters in patients with myasthenia gravis].
Liu WB; Men LN; Xia Q; He XT; Huang RX
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(47):3331-4. PubMed ID: 17313828
[TBL] [Abstract][Full Text] [Related]
7. [Clinical efficacy of Yiqi Qushi Recipe in treating myasthenia gravis and observation of its immunomodulatory effects].
Xu XQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Feb; 33(2):177-9. PubMed ID: 23646470
[TBL] [Abstract][Full Text] [Related]
8. Analysis on the Clinical Effect of High-Dose Glucocorticoids Combined with Immunosuppressants on Patients with Myasthenia Gravis Undergoing Video-Assisted Thoracoscopic Surgery.
Liu P; Wang H; Hu J; Zhai X; Ge Z
Biomed Res Int; 2021; 2021():5854056. PubMed ID: 34912892
[TBL] [Abstract][Full Text] [Related]
9. Plasma exchange for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2002; 2002(4):CD002275. PubMed ID: 12519572
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2003; (2):CD002277. PubMed ID: 12804431
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Immunonutrition on the Postoperative Complications in Thymoma with Myasthenia Gravis.
Xin Y; Cai H; Wu L; Cui Y
Mediators Inflamm; 2016; 2016():8781740. PubMed ID: 27956763
[No Abstract] [Full Text] [Related]
12. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2006 Apr; (2):CD002277. PubMed ID: 16625559
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis in Jamaican children: a 12-year institutional review.
Melbourne Chambers R; Forrester S; Gray R; Tapper J; Trotman H
Paediatr Int Child Health; 2012 Feb; 32(1):47-50. PubMed ID: 22525448
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka KV
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin for myasthenia gravis.
Gajdos P; Chevret S; Toyka K
Cochrane Database Syst Rev; 2008 Jan; (1):CD002277. PubMed ID: 18254004
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.
Howard JF; Bril V; Burns TM; Mantegazza R; Bilinska M; Szczudlik A; Beydoun S; Garrido FJRR; Piehl F; Rottoli M; Van Damme P; Vu T; Evoli A; Freimer M; Mozaffar T; Ward ES; Dreier T; Ulrichts P; Verschueren K; Guglietta A; de Haard H; Leupin N; Verschuuren JJGM;
Neurology; 2019 Jun; 92(23):e2661-e2673. PubMed ID: 31118245
[TBL] [Abstract][Full Text] [Related]
18. Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF; Bril V; Vu T; Karam C; Peric S; Margania T; Murai H; Bilinska M; Shakarishvili R; Smilowski M; Guglietta A; Ulrichts P; Vangeneugden T; Utsugisawa K; Verschuuren J; Mantegazza R;
Lancet Neurol; 2021 Jul; 20(7):526-536. PubMed ID: 34146511
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids in myasthenia gravis - if, when, how, and how much?
Hoffmann S; Kohler S; Ziegler A; Meisel A
Acta Neurol Scand; 2014 Oct; 130(4):211-21. PubMed ID: 25069701
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus Improves Symptoms of Children With Myasthenia Gravis Refractory to Prednisone.
Liu C; Gui M; Cao Y; Lin J; Li Y; Ji S; Bu B
Pediatr Neurol; 2017 Dec; 77():42-47. PubMed ID: 29074055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
